Pure Global

Role Of Serum Adiponectin In The Ealy Detection Of Renal Impairment In Patients With Non Alcoholic Fatty Liver Disease - Trial NCT05556135

Access comprehensive clinical trial information for NCT05556135 through Pure Global AI's free database. This phase not specified trial is sponsored by Assiut University and is currently Not yet recruiting. The study focuses on Renal Impairment. Target enrollment is 90 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT05556135
Not yet recruiting
diagnostic test
Trial Details
ClinicalTrials.gov • NCT05556135
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Role Of Serum Adiponectin In The Ealy Detection Of Renal Impairment In Patients With Non Alcoholic Fatty Liver Disease

Study Focus

Renal Impairment

level of serun adiponectin

Observational

diagnostic test

Sponsor & Location

Assiut University

Timeline & Enrollment

N/A

Oct 01, 2022

Oct 01, 2023

90 participants

Primary Outcome

Correlate serum Adiponectin level with renal impairment in non-alcoholic fatty liver disease.

Summary

Early detection of renal impairment in patients with Non-alcoholic fatty liver disease and
 its correlation with serum Adiponectin level.

ICD-10 Classifications

Renal failure
Disorders resulting from impaired renal tubular function
Disorder resulting from impaired renal tubular function, unspecified
Other disorders resulting from impaired renal tubular function
Acute renal failure

Data Source

ClinicalTrials.gov

NCT05556135

Non-Device Trial